Renub Research
www.renub.com
Influenza Vaccine Market Opportunities and
Challenges: Worldwide Forecast
Publisher: Renub Research
Published: January, 2012
Influenza Vaccine Market Overview
Last few years have seen renewed interest in the vaccines market, overcoming the prevailing
view that vaccines are a low-margin business with high barriers to entry. The flu vaccines
market has been at the forefront of this trend, partially fuelled by the fear of an impending
pandemic. As a result global influenza vaccine market has experienced phenomenal growth in
recent years at a compound annual growth rate of more than 65% between 2008 and 2010.
This growth was mainly driven by the global spread of H1N1 influenza. But in the year 2011
H1N1 pandemic flu vaccine market declined due to waning threat of swine flu disease.
However seasonal influenza vaccine market is predicted to grow year on year and cross US$ 4
Billion by 2015.
From our research findings Unites States is the largest market for influenza vaccine market in
2010. In seasonal influenza vaccine brands like Fluarix & Flulaval had highest sales for 2010.
Unlike some other pharmaceutical products, influenza vaccines are equally important in both
developed and developing nations. In the developing countries, dealing with infectious
diseases remains the highest priority in healthcare. It is predicted that in the next 5-6 years
seasonal influenza vaccine sales would increase significantly.
Renub Research report entitled “Influenza Vaccine Market Opportunities and Challenges:
Worldwide Forecast” critically examines the influenza vaccines market through a
comprehensive review of information. This report provides market prospects, Key products
detailed sales forecasts, discussions of pipeline developments and analyses of commercial
drivers and challenges, including revenue of key players from seasonal and H1N1 influenza
vaccine as well as Strengths and Weakness analysis of key players in influenza vaccine
segment.
This report examines the following markets for influenza vaccines:
Global Influenza vaccine market (2005 - 2015)
Global Seasonal influenza vaccine market has been covered from (2003 – 2015)
Global Swine Flu (H1N1) influenza vaccine market has been covered from (2009 – 2012)
© Renub Research Page 2 of 15
Top 7 Countries (United States, Germany, France, Italy, Spain, United Kingdom,
Japan) seasonal vaccine market data from (2005 – 2015)
Top Brands Seasonal influenza vaccine market performance (Fluarix, Afluria, Flumist,
Influvac) market performance and forecast
Top companies Swine Flu vaccine market performance (AstraZeneca, GlaxoSmithKline,
Novartis, Sanofi-Pasteur)
Companies Analysis
This section covers the key facts about the major companies that play an important role in
Influenza Vaccine Market. The companies analyzed in this section are – GlaxoSmithKline,
AstraZeneca, Novartis AG and Sanofi Pasteur. All the companies have been analyzed from
three headings
1) Revenue of the company from influenza vaccines (swine flu & seasonal flu)
2) Strength of the company in influenza vaccine market
3) Weakness of the company in influenza vaccine market
Data Sources
This report is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by Renub Research team of industry experts.
Information and data has been collected from various printable and non-printable sources like
search engines, News websites, Government Websites, Trade Journals, White papers,
Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals,
Industry Associations and access to more than 100 paid databases.
© Renub Research Page 3 of 15
About Us
Renub Research is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information
Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services
(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,
Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra-competitive markets.
For more information on us or to view any of our sample work you can
mail us at info@renub.com
© Renub Research Page 4 of 15
Published
By
Renub Research
A–116B, Sector–27
Noida – 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com
© Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
Renub Research, 2011
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers
© Renub Research Page 5 of 15
Table of Contents
1. Executive Summary
2. Worldwide Influenza Vaccine & Future Market
2.1 Worldwide Seasonal Influenza Vaccine & Future Market
2.2 Global Swine Flu (H1N1) Influenza Vaccine & Future Market
2.2.1 Global Pandemic Influenza Occur (1918 - 2009)
2.2.2 Country wise Swine Flu Vaccine Dose Order (2009)
2.3 Merger and Acquisition in Influenza Vaccine Market
3. Geographical Distribution – Seasonal Influenza Vaccine Market (2005 to 2015)
3.1 United States Seasonal Influenza Vaccine Market
3.2 Germany Seasonal Influenza Vaccine Market
3.3 France Seasonal Influenza Vaccine Market
3.4 Italy Seasonal Influenza Vaccine Market
3.5 Spain Seasonal Influenza Vaccine Market
3.6 United Kingdom Seasonal Influenza Vaccine Market
3.7 Japan Seasonal Influenza Vaccine Market
4. Worldwide – Seasonal Influenza Vaccine Brand Market & Forecast Pipeline Analysis
4.1 Fluarix & Flulaval - Sales Performance & Forecast
4.2 Afluria - Past, Present and Future Sales Performance
4.3 FluMist – Past, Present & Future Sales Performance
4.4 Influvac - Sales Performance & Future Forecast
5. Swine Flu Vaccine Market Analysis – Competitive Landscape
5.1 AstraZeneca Swine Flu Vaccine Sales Performance
5.2 GlaxoSmithKline Swine Flu Vaccine Sales Performance
5.3 Novartis Swine Flu Vaccines Sales Performance
5.4 Sanofi-Pasteur Swine Flu Vaccine Sales Performance
6. Growth Drivers in the Influenza Vaccines Market
6.1 Growing Prevalence of Influenza
© Renub Research Page 6 of 15
6.2 Emerging Vaccine Technologies
6.3 Effective Communication Strategies
6.4 Compliance with Vaccination
6.5 Vaccines most Cost Effective Means of Disease Prevention
7. Challenges for Influenza Vaccine Market
7.1 Barriers to Optimal use of Licensed Vaccines
7.1.1 Technical Obstacles
7.1.2 Economic Obstacles
7.1.3 Cultural Obstacles
7.2 Complexity of Influenza Vaccine Development & Approval System Thwarts Product
Development
7.2.1 Legal Obstacles
7.2.2 General Technical Barriers
7.2.3 Economic Barriers
7.2.4 Regulatory Barriers
7.3 Shortening the Timeline for Vaccine Development
8. Company Analysis
8.1 GlaxoSmithKline
8.1.1 GSK Influenza Vaccine Revenue
8.1.2 GSK Influenza Vaccine Strengths
8.1.3 GSK Influenza Vaccine Weakness
8.2 AstraZeneca
8.2.1 AstraZeneca Influenza Vaccine Revenue
8.2.2 AstraZeneca Influenza Vaccine Strengths
8.2.3 Astrazeneca Influenza Vaccine Weakness
8.3 Novartis AG
8.3.1 Novartis AG Influenza Vaccine Strengths
8.3.2 Novartis AG Influenza Vaccine Weakness
8.4 Sanofi Pasteur
8.4.1 Sanofi-Pasteur Influenza Vaccine Revenue
8.4.2 Sanofi-Pasteur Influenza Vaccine Strengths
8.4.3 Sanofi-Pasteur Influenza Vaccine Weakness
© Renub Research Page 7 of 15
List of Figures:
Figure 2-1: Worldwide – Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 2-2: Worldwide – Forecast for Influenza Vaccine Market (Million US$), 2011 – 2015
Figure 2-3: Worldwide – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 2-4: Worldwide – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 – 2015
Figure 2-5: Worldwide – Swine Flu (H1N1) Influenza Vaccine Market & Forecast (Million US$), 2009 –
2011
Figure 3-1: United-States – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 3-2: United States – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 – 2015
Figure 3-3: Germany – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 3-4: Germany – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 – 2015
Figure 3-5: France – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 3-6: France – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 – 2015
Figure 3-7: Italy – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 3-8: Italy – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 – 2015
Figure 3-9: Spain – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 3-10: Spain – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 – 2015
Figure 3-11: United Kingdom – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 3-12: United Kingdom – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2011 –
2015
Figure 3-13: Japan – Seasonal Influenza Vaccine Market (Million US$), 2005 – 2010
Figure 3-14: Japan – Forecast for Seasonal Influenza vaccine Market (Million US$), 2011 – 2015
Figure 4-1: Worldwide – Fluarix & Flulaval Vaccine Market (Million US$), 2007 – 2010
Figure 4-2: Worldwide – Forecast for Fluarix & Flulaval Vaccine Market (Million US$), 2011 – 2015
Figure 4-3: Worldwide – Afluria Vaccine Market (Million US$), 2008 – 2010
Figure 4-4: Worldwide – Forecast for Afluria Vaccine Market (Million US$), 2011 – 2015
Figure 4-5: Worldwide – Flumist Vaccine Market (Million US$), 2007 – 2010
Figure 4-6: Worldwide – Forecast for Flumist Vaccine Market (Million US$), 2011 – 2015
Figure 4-7: Worldwide – Influvac Vaccine Market (Million US$), 2006 – 2009
Figure 5-1: Astrazeneca – Swine Flu Vaccine Sales Performance & Future forecast (Million US$), 2009 –
2011
Figure 5-2: GSK – Swine Flu Vaccine Sales Performance & Future Forecast (Million US$), 2009 – 2011
Figure 5-3: Novartis – Swine Flu Vaccine Sales Performance & Future forecast (Million US$), 2009 –
2010
Figure 5-4: Sanofi Pasteur – Swine Flu Vaccine Sales Performance (Million US$), 2008 – 2010
Figure 9-1: Sanofi Pasteur – Influenza Vaccine Revenue (Million US$), 2007 – 2010
© Renub Research Page 8 of 15
List of Tables:
Table 2-1: Worldwide – Pandemic Influenza Vaccine Dose Orders (Million), 2009
Table 2-2: Worldwide – M&A Influenza Vaccine (Million US$), 2003, 2005, 2007, 2009 & 2010
Table 3-1: United States – Population (Million), 2005 – 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050
Table 3-2: Germany – Population (Million), 2005 – 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050
Table 3-3: France – Population (Million), 2005 – 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050
Table 3-4: Italy – Population (Million), 2005 – 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050
Table 3-5: Spain – Population (Million), 2005 – 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050
Table 3-6: United Kingdom – Population (Million), 2005 – 2015, 2020, 2025, 2030, 2035, 2040, 2045 &
2050
Table 3-7: Japan – Population (Million), 2005 – 2015, 2020, 2025, 2030, 2035, 2040, 2045 & 2050
Table 6-1: United States H1N1 – Related Hospitalizations and Deaths, By Age Group, April 2009 –
February 13, 2010
Table 6-2: Improvement Strategies or Requirements – the Joint Commission and the Project’s
Collaborating Organizations
Table 6-3: Seasonal Influenza Vaccination Compliance
Table 6-4: Pandemic Flu Vaccination Compliance
Table 6-5: Major Literature Findings Relevant to Influenza
Table 8-1: GlaxoSmithKline – Influenza Vaccine Revenue (Million US$), 2007 – 2010
Table 8-2: AstraZeneca – Influenza Vaccine Revenue (Million US$), 2007 – 2010
© Renub Research Page 9 of 15
Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com
Format
Report Title: Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
Single User Hard Copy CD – Rom Global Site License
(Email from Publisher) (Mail Delivery) (Mail Delivery) (Multiple User License)
US$ 1,100 US$ 1,200 US$ 1,200 US$ 2,000
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://renub.com/reports/showdetails.aspx?id=53
2) Order by Wire Transfer:
http://renub.com/reports/wiretransfer.aspx?id=53&pid=1190
To pay by Wire Transfer, please, fill in your contact details in the form below:
© Renub Research Page 10 of 15
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:
© Renub Research Page 11 of 15
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
A -116B
Sector -27
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch
© Renub Research Page 12 of 15
Related Reports
Genetic Testing Market and Forecast - Global Analysis 2010 – 2015
USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)
Global Osteoporosis Market & Drugs Analysis 2010 – 2015
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)
Global Molecular Diagnostics Market & Future Forecast 2010 - 2014
Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs
Analysis
Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)
World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)
Glucose Monitoring Devices Market Worldwide (2010 – 2014)
Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic Drug), Insulin,
DPP-IV, GLP-1
Global Molecular Diagnostics Market: Opportunities & Future Forecast
Insulin Delivery Devices Market Analysis and Future Forecast
World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments
© Renub Research Page 13 of 15
Our Partial List of Clients
Redbus Bain
Becton Dickinson WAKE Technology Services, Inc.
Pfizer PSS World Medical
Intercell Relypsa
Sanofi Pasteur C&K components
Stanford Burgess Konkuk University
Pequot Capital Resonetics
DMI Samsung
Transgene S.A. SEKISUI MEDICAL CO. LTD.
ixia communications Plentyoffish Media INC
Toyota Tsusho Amercia Inc. Arthur D Little Gmbh
National Health Research Institutes Morgan Stanley
Abbott Diabetes Care Takeda Pharmaceutical Corporation
Corning Incorporated - Life Sciences Hokkai School of Commerce
L.E.K. Consulting GmbH Ministry of Manpower Singapore
Syntiron GenOmind, LLC.
MediVas LLC Goldman Sachs & Co
Credit Suisse NTT Advanced Technology
Dune Medical Tokyo Womens Medical University
QIAGEN The Chemo-Sero-Therapeutic Research
Inje University Trade Council of Iceland
Mapp Biopharmaceutical Jpmorgan, Ets Trading
Institute for Information Industry GE Healthcare IT
NorDiag ASA ixia communications
© Renub Research Page 14 of 15
Rep e Inv Medicas SA de
Innogenetics
Disclaimer
This research report is published by Renub Research. All rights reserved. Reproduction or
redistribution of this research report in any form for any business purpose is expressly
prohibited without written permission of www.renub.com and any payments of a specified
fee. Requests to republish any material may be sent to us at info@renub.com.
Most of the information available in this report is within the public domain. The submitting
authors or other copyright holders retain rights for reproduction or redistribution. All persons
reproducing or redistributing this information are expected to adhere to the terms and
constraints invoked by the copyright holder. Such protected material, however, may be used
under the terms of "fair use” as defined in the copyright laws, which generally permit use for
non-commercial educational purposes such as teaching, research, criticism, and news
reporting.
With respect to documents available, neither the company nor any of its employees makes
any warranty, express or implied, including the warranties of merchantability and fitness for
a particular purpose, or assumes any legal liability or responsibility for the accuracy,
completeness, or usefulness of any information, apparatus, product, or process disclosed, or
represents that its use would not infringe privately owned rights.
© Renub Research Page 15 of 15